|
Jul 23
|
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
|
|
Jun 25
|
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
|
|
Dec 29
|
Kane Biotech Announces Correction to Press Release
|
|
Dec 28
|
Kane Biotech Announces Amendment to its Credit Facility
|
|
Dec 20
|
Kane Biotech Receives Offer for its Interest in STEM Animal Health
|
|
Nov 28
|
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
|
|
Oct 25
|
Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum
|
|
May 25
|
Kane Biotech Announces First Quarter 2023 Financial Results
|
|
May 25
|
Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel
|